| 1 |
23668619 | Response to imatinib in villonodular pigmented synovitis (PVNS) resistant to nilotinib. | 2013 May 13 |
2 |
| 2 |
22572726 | Pigmented villonodular synovitis therapy with MSCF-1 inhibitors. | 2012 Jul |
3 |
| 3 |
22096574 | The colony-stimulating factor-1 (CSF-1) receptor sustains ERK1/2 activation and proliferation in breast cancer cell lines. | 2011 |
2 |
| 4 |
20497911 | [Targeted treatment of rare connective tissue tumors and sarcomas]. | 2010 Jun |
1 |
| 5 |
18814279 | Imatinib mesylate suppresses bone metastases of breast cancer by inhibiting osteoclasts through the blockade of c-Fms signals. | 2009 Jan 1 |
3 |
| 6 |
18971950 | Imatinib sensitivity as a consequence of a CSF1R-Y571D mutation and CSF1/CSF1R signaling abnormalities in the cell line GDM1. | 2009 Feb |
1 |
| 7 |
18282599 | Multiple myeloma cells directly stimulate bone resorption in vitro by down-regulating mature osteoclast apoptosis. | 2008 Aug |
1 |
| 8 |
17907802 | Apoptotic killing of HIV-1-infected macrophages is subverted by the viral envelope glycoprotein. | 2007 Sep 7 |
1 |
| 9 |
15637141 | Macrophage colony-stimulating factor receptor c-fms is a novel target of imatinib. | 2005 Apr 15 |
5 |
| 10 |
15661041 | Imatinib inhibits the functional capacity of cultured human monocytes. | 2005 Feb |
2 |
| 11 |
12970769 | Imatinib inhibits the in vitro development of the monocyte/macrophage lineage from normal human bone marrow progenitors. | 2003 Sep |
1 |